cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Revolution Medicines Inc
3 own
4 watching
Current Price
$35.8
$-1.02
(-2.77%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,640.44M
52-Week High
52-Week High
38.73000
52-Week Low
52-Week Low
15.44000
Average Volume
Average Volume
0.17M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,640.44M
icon52-Week High38.73000
icon52-Week Low15.44000
iconAverage Volume0.17M
iconDividend Yield--
iconP/E Ratio--
What does the Revolution Medicines Inc do?
Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, high-value frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways.
Read More
How much money does Revolution Medicines Inc make?
News & Events about Revolution Medicines Inc.
Ticker Report
1 year ago
Revolution Medicines, Inc. (NASDAQ:RVMD Get Rating) Director Thilo Schroeder purchased 100,000 shares of the firms stock in a transaction on Friday, March 10th. The stock was acquired at an average price of $20.46 per share, for a total transaction of $2,046,000.00. Following the ...
Globe Newswire
1 year ago
REWOOD CITY, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced the pricing of its underwritten public offering of 13,636,364 shares of common stock at a ...
Market News Video
1 year ago
In trading on Thursday, shares of Revolution Medicines Inc (RVMD) touched a new 52-week high of 28.06/share. Thats a 99.29% rise, or 13.98 per share from the 52-week low of 14.08 set back on 05/12/2022...
Globe Newswire
1 year ago
Findings Published in the Journal of Medicinal Chemistry Demonstrate Compounds Exceptional Selectivity for mTORC1 over mTORC2 Tumor Regressions Observed During Combination Treatment with a Bi-Steric mTORC1-Selective Inhibitor and a KRASG12C-Selective Inhibitor in Preclinical Lung Cancer Model that ...
Frequently Asked Questions
Frequently Asked Questions
What is Revolution Medicines Inc share price today?
plus_minus_icon
Can Indians buy Revolution Medicines Inc shares?
plus_minus_icon
How can I buy Revolution Medicines Inc shares from India?
plus_minus_icon
Can Fractional shares of Revolution Medicines Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Revolution Medicines Inc stocks?
plus_minus_icon
What is today’s traded volume of Revolution Medicines Inc?
plus_minus_icon
What is today’s market capitalisation of Revolution Medicines Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Revolution Medicines Inc?
plus_minus_icon
What percentage is Revolution Medicines Inc down from its 52-Week High?
plus_minus_icon
What percentage is Revolution Medicines Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$35.8
$-1.02
(-2.77%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00